Stock 688506 SICHUAN BIOKIN PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sichuan Biokin Pharmaceutical Co.,Ltd.

Equities

688506

CNE100006FN4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
181.4 CNY -2.04% Intraday chart for Sichuan Biokin Pharmaceutical Co.,Ltd. -6.35% +29.66%
06-21 Sichuan Biokin Pharmaceutical Co.,Ltd. to Issue Shares and List in Hong Kong CI
06-17 Sichuan Biokin Pharmaceutical Co.,Ltd.(SHSE:688506) added to Shanghai Stock Exchange Health Care Sector Index CI

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 56,100 72,741 - -
Enterprise Value (EV) 1 56,100 72,741 72,741 72,741
P/E ratio -71.7 x 21.1 x 271 x 99.1 x
Yield - - - -
Capitalization / Revenue 99.8 x 11.9 x 28.9 x 23.7 x
EV / Revenue 99.8 x 11.9 x 28.9 x 23.7 x
EV / EBITDA -79.2 x 20 x 227 x 91.5 x
EV / FCF - 37.2 x 44.3 x 230 x
FCF Yield - 2.69% 2.26% 0.43%
Price to Book 369 x 20.2 x 18.8 x 15.8 x
Nbr of stocks (in thousands) 401,000 401,000 - -
Reference price 2 139.9 181.4 181.4 181.4
Announcement Date 4/26/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 561.9 6,134 2,518 3,069
EBITDA 1 - -708.7 3,635 321 795
EBIT 1 - -769.4 3,559 281 771
Operating Margin - -136.93% 58.02% 11.16% 25.12%
Earnings before Tax (EBT) 1 - -769 3,558 280 770
Net income 1 -286.1 -780.5 3,451 269 732
Net margin - -138.91% 56.26% 10.68% 23.85%
EPS 2 -0.7900 -1.950 8.610 0.6700 1.830
Free Cash Flow 1 - - 1,957 1,643 315.6
FCF margin - - 31.91% 65.24% 10.28%
FCF Conversion (EBITDA) - - 53.85% 511.79% 39.7%
FCF Conversion (Net income) - - 56.72% 610.72% 43.11%
Dividend per Share - - - - -
Announcement Date 2/27/23 4/26/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - - 1,957 1,643 316
ROE (net income / shareholders' equity) - -144% 95.8% 7% 15.9%
ROA (Net income/ Total Assets) - - 75.3% 5.5% 13%
Assets 1 - - 4,583 4,891 5,631
Book Value Per Share 2 - 0.3800 8.980 9.660 11.50
Cash Flow per Share - - - - -
Capex 1 - 81.9 81.9 80.2 80.3
Capex / Sales - 14.57% 1.34% 3.18% 2.62%
Announcement Date 2/27/23 4/26/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
181.4 CNY
Average target price
226 CNY
Spread / Average Target
+24.59%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SICHUAN BIOKIN PHARMACEUTICAL CO.,LTD. Stock Sichuan Biokin Pharmaceutical Co.,Ltd.
+29.66% 10.01B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 224B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688506 Stock
  4. Financials Sichuan Biokin Pharmaceutical Co.,Ltd.